0001209191-23-031941.txt : 20230524 0001209191-23-031941.hdr.sgml : 20230524 20230524175131 ACCESSION NUMBER: 0001209191-23-031941 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230523 FILED AS OF DATE: 20230524 DATE AS OF CHANGE: 20230524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Callori Fred CENTRAL INDEX KEY: 0001843393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39971 FILM NUMBER: 23955315 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Landos Biopharma, Inc. CENTRAL INDEX KEY: 0001785345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815085535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 BUSINESS PHONE: 540-818-2844 MAIL ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-23 0 0001785345 Landos Biopharma, Inc. LABP 0001843393 Callori Fred C/O LANDOS BIOPHARMA, INC. PO BOX 11239 BLACKSBURG VA 24062 1 0 0 0 0 Stock Option (right to buy) 0.33 2023-05-23 4 A 0 18000 0.00 A 2033-05-22 Common Stock 18000 18000 D The shares subject to this option will vest and become exercisable on May 23, 2024, subject to the Reporting Person providing continuous service through such date. /s/ Eric W. Blanchard, Attorney-in-Fact 2023-05-24